Diagnosis and Therapy of Atrial Tachyarrhythmias in the Dual Chamber Implantable Cardioverter Defibrillator
Authors:
- 1 November 2000
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 11 (11) , 1196-1205
Abstract
Atrial Arrhythmias in ICD Patients. Introduction: Devices capable of monitoring and treating atrial taihyarrhythmias provide information about the natural history of the arrbythmias and potentially can influence their natural course by electrical therapy early after onset.Methods and results: Types of atrial arrhythmias and efficacy of device therapies were evaluated in 30 patients implanted with the Medtronic model 7250 Jewel AF implantable cardioverter defibrillator (ICD). All patients had structural heart disease and documented sustained ventricular and atrial arrhythmias (27 with atrial fibrillation [AF]) before implant. Twenty patients were taking amiodarone, and three were taking sotalol. During 20 ± 10 months of follow‐up, 600 atrial arrhythmia recurrences were documented in 50% of patients. AF was diagnosed in 19%. fast polymorphic atrial tacbycardia (AT) in 20%, fast monomorpbic AT in 57%. and slow AT in 4% of episodes. The two adaptive pacing therapies, burst and ramp, together with the 50‐Hz burst, were successful in 57% of delected atrial arrhythmias. Burst and ramp were responsible for 49% and 50‐Hz burst for 51% of successfully treated arrbytbmias; 33% of the episodes terminated spontaneously. No ventricular proarrbythmia was observed due to atrial pacing therapies. In 30% of episodes, dual chamber pacing was required due to post termination bradycardia. Atrial arrhythmia recurrences in patients with dilated cardiomyopathy were not amenable to pacing therapies. Several aspects of atrial arrhythmia diagnosis, therapy, and documentation that are specific for functioning of the Jewel AF arc discussed.Conclusion: Atrial arrhythmias in ICD patients with diseased hearts who are taking Class III antiarrbythmics frequently had longer cycle lengths than AF. Half of these arrhythmias could be terminated with pacing therapies; one third terminated spontaneously.Keywords
This publication has 11 references indexed in Scilit:
- Atrial Fibrillation Produced by Prolonged Rapid Atrial Pacing Is Associated With Heterogeneous Changes in Atrial Sympathetic InnervationCirculation, 2000
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- What is the relationship of atrial flutter and fibrillation?Pacing and Clinical Electrophysiology, 1999
- Atrial Electrograms and Activation Sequences in the Transition Between Atrial Fibrillation and Atrial FlutterJournal of Cardiovascular Electrophysiology, 1998
- Hybrid Pharmacologic and Ablative Therapy: A Novel and Effective Approach for the Management of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 1998
- Relationship Between Atrial Fibrillation and Typical Atrial Flutter in HumansCirculation, 1997
- Simultaneous Multisite Mapping Studies During Induced Atrial Fibrillation in the Sterile Pericarditis ModelCirculation, 1997
- Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration Evidence of a fully excitable gap in the reentrant circuitJACC, 1996
- Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.Circulation, 1994
- Characterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery*Pacing and Clinical Electrophysiology, 1978